Hans‐Peter Hartung
Researcher Next ID · RN-004610
Researcher · Medicine
Sydney, Australia
- Works count
- 1,109
- Citation count
- 67,330
- H-index
- 112
- i10-index
- 598
Research interests
Publications
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1601277
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606468
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0907839
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Annals of Neurology · 2005 · https://doi.org/10.1002/ana.20703
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
Annals of Neurology · 2001 · https://doi.org/10.1002/ana.1032
Current projects
No projects listed.